tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SPRY Stock Latest News

Ars Pharmaceuticals’ Latest Study: A Potential Game-Changer in Allergy Treatment
Company AnnouncementsArs Pharmaceuticals’ Latest Study: A Potential Game-Changer in Allergy Treatment
2d ago
SPRY
Ars Pharmaceuticals’ Promising Study on ARS-2 for Chronic Urticaria: What Investors Need to Know
PremiumCompany Announcements
Ars Pharmaceuticals’ Promising Study on ARS-2 for Chronic Urticaria: What Investors Need to Know
2d ago
SPRY
ARS Pharmaceuticals receives favorable decision from EPO on neffy
PremiumThe Fly
ARS Pharmaceuticals receives favorable decision from EPO on neffy
21d ago
SPRY
ARS Pharmaceuticals: Strategic Financial Maneuvers and Market Potential Drive Buy Rating
PremiumRatings
ARS Pharmaceuticals: Strategic Financial Maneuvers and Market Potential Drive Buy Rating
30d ago
SPRY
ARS Pharmaceuticals Secures $250 Million Credit Agreement
PremiumCompany Announcements
ARS Pharmaceuticals Secures $250 Million Credit Agreement
1M ago
8K
SPRY
ARS Pharmaceuticals Gains Momentum: Buy Rating Justified by Market Share and Script Volume Increase
PremiumRatingsARS Pharmaceuticals Gains Momentum: Buy Rating Justified by Market Share and Script Volume Increase
1M ago
SPRY
Raymond James positive on ARS Pharmaceuticals after weekly data
Premium
The Fly
Raymond James positive on ARS Pharmaceuticals after weekly data
1M ago
SPRY
3 Best Stocks to Buy Now, 9/23/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 9/23/2025, According to Top Analysts
1M ago
ADVM
ATAI
Global Expansion and Strategic Advancements Drive Buy Rating for ARS Pharmaceuticals
PremiumRatings
Global Expansion and Strategic Advancements Drive Buy Rating for ARS Pharmaceuticals
1M ago
SPRY
ARS Pharmaceuticals announces neffy approved in Japan
PremiumThe Fly
ARS Pharmaceuticals announces neffy approved in Japan
1M ago
SPRY
ARS Pharmaceuticals: Strengthened Buy Rating Following Positive Real-World Data on Neffy
PremiumRatings
ARS Pharmaceuticals: Strengthened Buy Rating Following Positive Real-World Data on Neffy
2M ago
SPRY
ARS Pharmaceuticals announces real-world evidence on neffy effectiveness
PremiumThe Fly
ARS Pharmaceuticals announces real-world evidence on neffy effectiveness
2M ago
SPRY
Roth starts ARS Pharmaceuticals at Buy, sees ‘vast improvement’ from Neffy
PremiumThe FlyRoth starts ARS Pharmaceuticals at Buy, sees ‘vast improvement’ from Neffy
2M ago
SPRY
ARS Pharmaceuticals initiated with a Buy at Roth Capital
Premium
The Fly
ARS Pharmaceuticals initiated with a Buy at Roth Capital
2M ago
SPRY
Short Report: C3.AI short positioning at 2025-high
Premium
The Fly
Short Report: C3.AI short positioning at 2025-high
2M ago
AI
TEM
Ars Pharmaceuticals Reports Strong Q2 Growth and Global Expansion
PremiumCompany Announcements
Ars Pharmaceuticals Reports Strong Q2 Growth and Global Expansion
2M ago
SPRY
ARS Pharmaceuticals Faces Patent Challenge from Lupin
PremiumCompany Announcements
ARS Pharmaceuticals Faces Patent Challenge from Lupin
2M ago
8K
SPRY
ARS Pharmaceuticals: Strong Market Position and Growth Potential Justify Buy Rating
PremiumRatings
ARS Pharmaceuticals: Strong Market Position and Growth Potential Justify Buy Rating
2M ago
SPRY
ARS Pharmaceuticals Reports Strong Growth for neffy
PremiumCompany Announcements
ARS Pharmaceuticals Reports Strong Growth for neffy
3M ago
SPRY
ARS Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsARS Pharmaceuticals Reports Q2 2025 Financial Results
3M ago
8K
SPRY
ARS Pharmaceuticals sees cash runway for at least next three years
Premium
The Fly
ARS Pharmaceuticals sees cash runway for at least next three years
3M ago
SPRY
ARS Pharmaceuticals reports reports Q2 EPS (46c), consensus (51c)
Premium
The Fly
ARS Pharmaceuticals reports reports Q2 EPS (46c), consensus (51c)
3M ago
SPRY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >